Grand Rounds - May 14, 2021
"COVID and You"
Speaker: Jackie Shannon, PhD. Director for Community-Engaged Research, Knight Cancer Institute - Oregon Health and Science University.
UPDATE: Co-Administration of COVID-19 with Other Vaccines
As of Friday, May 14th, 2021 the Center for Disease Control and Prevention is now allowing Co-Administration of Vaccines:
During her Grand Rounds Presentation (linked above), Jackie Shannon, PhD, had mentioned that HPV vaccinations could NOT be administered concurrently with the COVID-19 vaccine.
COVID-19 vaccines were previously recommended to be administered alone, with a minimum interval of 14 days before or after administration of any other vaccines. This was out of an abundance of caution and not due to any known safety or immunogenicity concerns. However, substantial data have now been collected regarding the safety of COVID-19 vaccines currently authorized by FDA for use under EUA. Although data are not available for COVID-19 vaccines administered simultaneously with other vaccines, extensive experience with non-COVID-19 vaccines has demonstrated that immunogenicity and adverse event profiles are generally similar when vaccines are administered simultaneously as when they are administered alone.
COVID-19 vaccines and other vaccines may now be administered without regard to timing. This includes simultaneous administration of COVID-19 vaccines and other vaccines on the same day, as well as coadministration within 14 days. It is unknown whether reactogenicity of COVID-19 vaccine is increased with coadministration, including with other vaccines known to be more reactogenic, such as adjuvanted vaccines or live vaccines. When deciding whether to coadminister another vaccine(s) with COVID-19 vaccines, providers should consider whether the patient is behind or at risk of becoming behind on recommended vaccines, their risk of vaccine-preventable disease (e.g., during an outbreak or occupational exposures), and the reactogenicity profile of the vaccines.
If multiple vaccines are administered at a single visit, administer each injection in a different injection site. For adolescents and adults, the deltoid muscle can be used for more than one intramuscular injection.
Best practices for multiple injections include:
- Label each syringe with the name and the dosage (amount) of the vaccine, lot number, the initials of the preparer, and the exact beyond-use time, if applicable.
- Separate injection sites by 1 inch or more, if possible.
- Administer the COVID-19 vaccines and vaccines that may be more likely to cause a local reaction (e.g., tetanus-toxoid-containing and adjuvanted vaccines) in different limbs, if possible.
Objectives
- Identify recent changes in cancer screening and incidence post COVID onset
- Describe the design and intent of the COVID and You survey
- Summarize the COVID and You findings from the complete sample and specific to three central Oregon counties
- Discuss how based on survey findings, how COVID has impacted cancer prevention, screening and survivorship in our state and region
Accreditation: St. Charles Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. St. Charles Health System designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Claim Credit
Target Audience: Physicians, Nurses, Pharmacists, Allied Health Professionals
Accessibility/Program Questions: St. Charles Health System encourages persons with disabilities to participate in its programs and activities. If you anticipate needing any type of accommodation or have questions about the physical access provided, please contact Continuing Medical Education at 541-706-4680, cme@stcharleshealthcare.org. For CME or Clerkship questions, contact Sheila Jordan, MMGT, CHCP, Manager of Continuing Medical Education at 541-706-6780, ssjordan@stcharleshealthcare.org.
